Literature DB >> 17627894

State medical board members' beliefs about pain, addiction, and diversion and abuse: a changing regulatory environment.

Aaron M Gilson1, Martha A Maurer, David E Joranson.   

Abstract

UNLABELLED: Three national surveys were conducted in 1991, 1997, and 2004 to evaluate state medical board members' knowledge and attitudes about prescribing opioid analgesics for pain management. Topics addressed include perceived legality of prolonged opioid prescribing, characteristics of addiction, prevalence of medication abuse and diversion, and perceived importance and influence of medical board policy. Questions were added in 2004 to determine board members' views about law enforcement involvement in physician investigations and prosecutions. This study assesses medical regulators' current beliefs and compares the 2004 responses with previous responses to determine how knowledge and attitudes about prescribing opioids have changed in recent years. Survey results show that board members have a greater understanding of pain management issues, particularly regarding characteristics of addiction and the legality of prolonged opioid prescribing for chronic noncancer pain. During the last 15 years, there has been substantial regulatory policy development, with medical boards adopting regulations, guidelines, or policy statements to provide guidance to licensees about using opioids to treat pain. However, many board members believe that federal and state law enforcement agencies have increased criminal investigations and prosecutions of physicians. We discuss appropriate regulatory and law enforcement responses to opioid prescribing violations, and suggest crucial next steps. PERSPECTIVE: The authors examine the evolution of state medical board members' knowledge and attitudes about prescribing opioid analgesics to treat chronic pain, demonstrate that medical regulators believe that there have been increased criminal investigations and prosecutions of physicians for their prescribing practices, and suggest ways to avoid unwarranted criminal prosecutions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17627894     DOI: 10.1016/j.jpain.2007.05.012

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  12 in total

Review 1.  Opioid formulations designed to resist/deter abuse.

Authors:  Robert B Raffa; Joseph V Pergolizzi
Journal:  Drugs       Date:  2010-09-10       Impact factor: 9.546

2.  Computerized progress notes for chronic pain patients receiving opioids; the Prescription Opioid Documentation System (PODS).

Authors:  Barth L Wilsey; Scott M Fishman; Carlos Casamalhuapa; Naileshni Singh
Journal:  Pain Med       Date:  2010-11       Impact factor: 3.750

Review 3.  Police officer, deal-maker, or health care provider? Moving to a patient-centered framework for chronic opioid management.

Authors:  Christina Nicolaidis
Journal:  Pain Med       Date:  2011-05-03       Impact factor: 3.750

4.  Age and sex trends in long-term opioid use in two large American health systems between 2000 and 2005.

Authors:  Stephen M Thielke; Linda Simoni-Wastila; Mark J Edlund; Andrea DeVries; Bradley C Martin; Jennifer B Braden; Ming-Yu Fan; Mark D Sullivan
Journal:  Pain Med       Date:  2009-11-25       Impact factor: 3.750

5.  Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.

Authors:  Roger Chou; Gilbert J Fanciullo; Perry G Fine; Jeremy A Adler; Jane C Ballantyne; Pamela Davies; Marilee I Donovan; David A Fishbain; Kathy M Foley; Jeffrey Fudin; Aaron M Gilson; Alexander Kelter; Alexander Mauskop; Patrick G O'Connor; Steven D Passik; Gavril W Pasternak; Russell K Portenoy; Ben A Rich; Richard G Roberts; Knox H Todd; Christine Miaskowski
Journal:  J Pain       Date:  2009-02       Impact factor: 5.820

6.  Predictors of high score patient-reported barriers to controlling cancer pain: a preliminary report.

Authors:  Jung Hye Kwon; Sung Yong Oh; Gary Chisholm; Jung-Ae Lee; Jae Jin Lee; Keon Woo Park; Seung-Hyun Nam; Hun Ho Song; Keehyun Lee; Dae Young Zang; Ho Young Kim; Dae Ro Choi; Hyo Jung Kim; Jung Han Kim; Joo Young Jung; Geundoo Jang; Hyeong Su Kim; Ji Yun Won; Eduardo Bruera
Journal:  Support Care Cancer       Date:  2012-11-15       Impact factor: 3.603

7.  Trends in long-term opioid therapy for chronic non-cancer pain.

Authors:  Denise Boudreau; Michael Von Korff; Carolyn M Rutter; Kathleen Saunders; G Thomas Ray; Mark D Sullivan; Cynthia I Campbell; Joseph O Merrill; Michael J Silverberg; Caleb Banta-Green; Constance Weisner
Journal:  Pharmacoepidemiol Drug Saf       Date:  2009-12       Impact factor: 2.890

8.  Prescription opioid abuse: challenges and opportunities for payers.

Authors:  Nathaniel P Katz; Howard Birnbaum; Michael J Brennan; John D Freedman; Gary P Gilmore; Dennis Jay; George A Kenna; Bertha K Madras; Lisa McElhaney; Roger D Weiss; Alan G White
Journal:  Am J Manag Care       Date:  2013-04       Impact factor: 2.229

9.  Development of the KnowPain-12 pain management knowledge survey.

Authors:  Debra B Gordon; John D Loeser; David Tauben; Tessa Rue; Agnes Stogicza; Ardith Doorenbos
Journal:  Clin J Pain       Date:  2014-06       Impact factor: 3.442

10.  Morphinofobia: the situation among the general population and health care professionals in North-Eastern Portugal.

Authors:  Henk Verloo; Emmanuel K Mpinga; Maria Ferreira; Charles-Henri Rapin; Philippe Chastonay
Journal:  BMC Palliat Care       Date:  2010-06-22       Impact factor: 3.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.